Clinical Trial of 26,26,26,27,27,27-Hexafluoro-1,25-Dihydroxyvitamin D3 in Uremic Patients on Hemodialysis: Preliminary Report

Calcium-Regulating Hormones I - Contributions to Nephrology ◽

10.1159/000420143 ◽

2015 ◽

pp. 196-203 ◽

Author(s):

Yoshiki Nishizawa ◽

Hirotoshi Morii ◽

Yosuke Ogura ◽

Hector F. DeLuca

Keyword(s):

Clinical Trial ◽

Preliminary Report ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3 ◽

Uremic Patients

Download Full-text

Calendar of forthcoming events27,27-hexafluoro-1,25-dihydroxyvitamin D3 in uremic patients on hemodialysis: Preliminary report

Bone and Mineral ◽

10.1016/0169-6009(92)90825-x ◽

1992 ◽

Vol 16 (1) ◽

pp. 85-86

Keyword(s):

Preliminary Report ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3 ◽

Uremic Patients

Download Full-text

Clinical Effects of 1,25-Dihydroxyvitamin D3 in Uremic Patients with Overt Osteodystrophy

Contributions to Nephrology - Uses and Actions of 1,25-Dihydroxyvitamin D3 in Uremia ◽

10.1159/000403271 ◽

2015 ◽

pp. 29-41 ◽

Author(s):

Arnold S. Brickman ◽

Jack W. Coburn ◽

Donald J. Sherrard ◽

Eugene G. C. Wong ◽

Anthony W. Norman ◽

...

Keyword(s):

Clinical Effects ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3 ◽

Uremic Patients

Download Full-text

Characterization of the activation function-2 domain of the human 1,25-dihydroxyvitamin D3 receptor1A preliminary report of some of the data presented in this manuscript was presented at the annual meeting of the American Society for Bone and Mineral Research, Baltimore, September, 1995.1

Molecular and Cellular Endocrinology ◽

10.1016/s0303-7207(98)00077-x ◽

1998 ◽

Vol 139 (1-2) ◽

pp. 15-24 ◽

Author(s):

Shigeo Nakajima ◽

Masayo Yamagata ◽

Norio Sakai ◽

Keiichi Ozono

Keyword(s):

Annual Meeting ◽

Preliminary Report ◽

Activation Function ◽

Mineral Research ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3 ◽

American Society

Download Full-text

Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients

American Journal of Kidney Diseases ◽

10.1053/ajkd.2003.50097 ◽

2003 ◽

Vol 41 (3) ◽

pp. S108-S111 ◽

Author(s):

Masako Yasuda ◽

Takashi Akiba ◽

Hiroshi Nihei

Keyword(s):

Clinical Trial ◽

Chronic Dialysis ◽

Multicenter Clinical Trial ◽

Dialysis Patients ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3

Download Full-text

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

Journal of Clinical Investigation ◽

10.1172/jci116720 ◽

1993 ◽

Vol 92 (3) ◽

pp. 1436-1443 ◽

Author(s):

N Fukuda ◽

H Tanaka ◽

Y Tominaga ◽

M Fukagawa ◽

K Kurokawa ◽

...

Keyword(s):

Severe Form ◽

Parathyroid Hyperplasia ◽

D3 Receptor ◽

Receptor Density ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3 ◽

Uremic Patients

Download Full-text

Pilot study of topical calcitriol (1,25-dihydroxyvitamin D3) for treating psoriasis in children

Archives of Dermatology ◽

10.1001/archderm.131.8.961 ◽

1995 ◽

Vol 131 (8) ◽

pp. 961-962 ◽

Author(s):

A. Perez

Keyword(s):

Pilot Study ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3

Download Full-text

Faculty Opinions recommendation of Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1347975.3123054 ◽

2010 ◽

Author(s):

Jack Satsangi

Keyword(s):

Crohn Disease ◽

Innate Immune ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3 ◽

Immune Pathway ◽

Innate Immune Pathway

Download Full-text

Faculty Opinions recommendation of 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718158993.793507551 ◽

2015 ◽

Author(s):

Phyllis Leppert

Keyword(s):

Extracellular Matrix ◽

Protein Expression ◽

Uterine Fibroid ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3

Download Full-text

Faculty Opinions recommendation of 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718203542.793501562 ◽

2014 ◽

Author(s):

Robyn Lucas

Keyword(s):

T Helper Cell ◽

Helper Cell ◽

T Helper ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3

Download Full-text

1,25-Dihydroxyvitamin D3 Restrains CD4+ T Cell Priming Ability of CD11c+ Dendritic Cells by Upregulating Expression of CD31

Frontiers in Immunology ◽

10.3389/fimmu.2019.00600 ◽

2019 ◽

Vol 10 ◽

Author(s):

Louise Saul ◽

Iris Mair ◽

Alasdair Ivens ◽

Pamela Brown ◽

Kay Samuel ◽

...

Keyword(s):

Dendritic Cells ◽

T Cell ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3 ◽

Download Full-text